Britain's increase in alcohol tax led to soaring prices

The British Wine and Spirits Association reported that the dramatic increase in taxes led to an increase in the prices of all types of alcoholic beverages.

According to the latest report of the association, from the beginning of this year to May 14th, the sales volume of spirits in the UK market was the same as that of the same period of last year, but sales increased by 6%.

Wine sales fell 2% compared to the same period last year, but sales increased by 3%. Below 3 pounds/bottle of wine sales fell 42%, 3 pounds to 4 pounds/bottle of wine sales fell 20%; 4 pounds to 5 pounds/bottle of wine sales rose 24%.

Palbociclib is a drug for the treatment of ER-positive and HER2-negative breast cancer developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
It was reviewed and approved under the Food and Drug Administration`s (FDA) accelerated Priority Review and Breakthrough Therapy designation programs on February 3, 2015 as a treatment (in combination with letrozole) for patients with estrogen receptor positive advanced breast cancer.
We produce a series of complete intermediates for Palbociclib, intermediate I (CAS No. 571188-59-5), intermediate II (CAS No. 1013916-37-4) and intermediate III (CAS No. 1016636-76-2) etc.

All of our products are with stable production and strict quality control, making sure your experience with Sunshine Biotech is always enriching, satisfying and fulfilling.

Pharmaceutical Intermediates

Palbociclib Intermediates

Palbociclib Intermediates,Cas 571188-59-5,Cas 1013916-37-4,Cas 1016636-76-2

Nanjing Sunshine Biotech Co., Ltd ,